GLYBURIDE CONTAINING COMPOSITION Russian patent published in 2005 - IPC

Abstract RU 2244707 C2

FIELD: pharmaceutical agents, in particular glyburide containing composition.

SUBSTANCE: claimed composition contains 5-chloro-N-[2-[4-[[(cyclohexylamino) carbonyl]amino]sulfonyl]ethyl]-2-methoxybenzamide, known under generic name as glyburide, and has the next grain-size classification (%): undersize of 3-11 mum - 25; undersize of 6-23 mum - 50 %, and undersize of 15-46 mum - 75 %. Such grain-size classification affords the ability to increase glyburide dissolution rate and provide reproducible biological availability of glyburide.

EFFECT: pharmaceutical composition useful for treatment of II- type diabetes.

11 cl, 2 tbl, 6 ex

Similar patents RU2244707C2

Title Year Author Number
METHOD FOR DIABETES TREATMENT 2000
  • Pajper Bet Ehnn
RU2275915C2
ANTI-DIABETIC PREPARATION AND METHOD FOR TREATMENT OF DIABETES MELLITUS 2000
  • Pajper Bet Ehnn
RU2276604C2
SOLID DOSED MEDICINAL FORMULATION FOR ORAL USING CONTAINING COMBINATION OF METFORMIN AND GLIBENCLAMIDE 1999
  • Bonomm Iv
  • Nikolson Dzheffri
  • Kejv Dzhillian
  • Nikolson Sara Dzh.
RU2226396C2
SOLID DOZED PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING COMBINATION OF METFORMIN AND GLIBENCLAMIDE 1999
  • Bonomm Iv
  • Nikolson Dzheffri
  • Kejv Dzhillian
  • Nikolson Sara Dzh.
RU2286788C2
SOLID PHARMACEUTICAL FORM OF INDOLE-3-CARBINOL 2017
  • Kisilev Aleksej Pavlovich
  • Rogova Natalya Viktorovna
RU2680967C2
WAY OF RECEPTION OF PHARMACEUTICAL COMPOSITION IN FORM OF TABLETS CONTAINING FIBRATE AND TABLETS MADE IN THIS WAY 2004
  • Bess Zherom
RU2362547C2
PHARMACEUTICAL COMPOSITIONS OF ENTACAPONE, LEVODOPA AND CARBIDOPA WITH IMPROVED BIOAVAILABILITY 2009
  • Talvar Munish
  • Kapur Ritesh
  • Mashalkar Manodzh
  • Dzhain Girish Kumar
RU2485947C2
GASTRORESISTANT PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMIN 2006
  • Viskomi Dzhuzeppe K.
  • Paladzini Ehrnesto
  • Tsamboni Villiam
  • Pantaleo Marija Rozarija
RU2403015C2
PHARMACEUTICAL COMPOSITIONS COMPRISING 5,8,14-TRIAZATETRACYCLO[10,3,1,0(2,11),0(4,9)HEXADECA-2( 11),3,5,7,9-PENTAENE 2002
  • Am Ehnde Mehri Tanja
  • Roj Majkl Kristofer
  • Smit Skott Uehndell
  • Uoterman Kennet Krehjg
  • Mouzes Sara Kristen
  • Kvan Ehrnest Shing
RU2272629C2
COMPOSITIONS OF ORALLY DISPERSIBLE TABLETS CONTAINING COMBINATIONS OF HIGH- AND LOW-DOSE THERAPEUTIC AGENTS 2010
  • Venkatesh Gopi M.
  • Clevenger James
  • Gosselin Michael
  • Lai Jin-Wang
RU2554740C2

RU 2 244 707 C2

Authors

Kehjv Dzhillian

Nicholson Sara Dzh.

Dates

2005-01-20Published

2001-01-04Filed